Atara Biotherapeutics, Inc.

ATRA · Healthcare

$9.76

Markedsværdi: 97.97M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Atara Biotherapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Associated Press12. aug. 2026, 20.10

Atara Biotherapeutics: Q2 Earnings Snapshot

Business Wire12. aug. 2026, 20.05

Atara Biotherapeutics Announces Second Quarter 2026 Financial Results and Operational Progress

Business Wire12. jun. 2026, 20.00

Atara Biotherapeutics Announces Changes to Its Board of Directors

GlobeNewswire11. jun. 2026, 10.52

Quetzal Therapeutics Announces First Patient Dosed in Phase 3 QUATRO-APL Trial of QTX-2101 for Frontline Acute Promyelocytic Leukemia